Suchergebnisse - "Anti-Retroviral Agents/adverse effects"

Antiretroviral drug exposure in pregnancy and risk of congenital anomalies: a European case/non-case malformed study

Autoren: Saint‐lary, Laura Beau, Anna-Belle Sommet, Agnès et al.

Weitere Verfasser: Saint‐lary, Laura Beau, Anna-Belle Sommet, Agnès et al.

Quelle: Eur J Clin Pharmacol
European journal of clinical pharmacology, vol. 81, no. 5, pp. 697-709

Schlagwörter: Adult, Congenital anomalies, Databases, Factual, Anti-HIV Agents, [SDV]Life Sciences [q-bio], Research, Humans, Pregnancy, Female, Abnormalities, Drug-Induced/epidemiology, Abnormalities, Drug-Induced/etiology, Europe/epidemiology, Anti-HIV Agents/adverse effects, Pregnancy Complications, Infectious/drug therapy, HIV Infections/drug therapy, Registries, Infectious Disease Transmission, Vertical/prevention & control, Zidovudine/adverse effects, Anti-Retroviral Agents/adverse effects, Young Adult, Antiretroviral drug, First trimester exposure, HIV, Abnormalities, Drug-Induced, HIV Infections, Infectious Disease Transmission, Vertical, [SDV] Life Sciences [q-bio], Europe, Anti-Retroviral Agents, Pregnancy Complications, Infectious, Zidovudine

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/40011239
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_9FB809F971D86
https://serval.unil.ch/notice/serval:BIB_9FB809F971D8
https://serval.unil.ch/resource/serval:BIB_9FB809F971D8.P001/REF.pdf

Preferences of People Living with HIV for Long-Acting Antiretroviral Treatment in Germany: Evidence from a Discrete Choice Experiment

Autoren: Martin Emmert Stefan Rohrbacher Jennifer Jahn et al.

Quelle: Patient

Schlagwörter: Male, Adult, HIV, Patient Preference, HIV Infections, Middle Aged, Choice Behavior, 3. Good health, Anti-Retroviral Agents, Germany, Humans, Female, Original Research Article, Anti-Retroviral Agents/adverse effects [MeSH], Female [MeSH], HIV [MeSH], Male [MeSH], Patient Preference [MeSH], Adult [MeSH], HIV Infections/drug therapy [MeSH], Germany [MeSH], Humans [MeSH], Middle Aged [MeSH], Choice Behavior [MeSH]

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37436659
https://repository.publisso.de/resource/frl:6485411

CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study

Autoren: Chammartin, Frédérique Darling, Katharine Abela, Irene A et al.

Weitere Verfasser: Chammartin, Frédérique Darling, Katharine Abela, Irene A et al.

Quelle: J Acquir Immune Defic Syndr
Journal of acquired immune deficiency syndromes, vol. 91, no. 5, pp. 508
Chammartin, Frédérique; Darling, Katharine; Abela, Irene A; Battegay, Manuel; Furrer, Hansjakob; Calmy, Alexandra; Bernasconi, Enos; Schmid, Patrick; Hoffmann, Matthias; Bucher, Heiner C (2022). CD4:CD8 ratio and CD8 cell count and their prognostic relevance for coronary heart disease events and stroke in antiretroviral treated individuals: The Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes JAIDS, 91(5), pp. 508-515. Lippincott Williams & Wilkins 10.1097/QAI.0000000000003094 <http://dx.doi.org/10.1097/QAI.0000000000003094>

Schlagwörter: 10028 Institute of Medical Virology, CD4-Positive T-Lymphocytes, Anti-HIV Agents, CD4-CD8 Ratio, 610 Medicine & health, HIV Infections, Coronary Disease, HIV Infections / complications, CD8-Positive T-Lymphocytes, 10234 Clinic for Infectious Diseases, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Humans, HIV Infections/complications, HIV Infections/drug therapy, Prognosis, Cardiovascular Diseases/drug therapy, Switzerland, Anti-Retroviral Agents/adverse effects, Viral Load, Biomarkers, Coronary Disease/epidemiology, Stroke/epidemiology, CD4 Lymphocyte Count, Anti-HIV Agents/adverse effects, 2736 Pharmacology (medical), Stroke / epidemiology, Cardiovascular Diseases / drug therapy, 2725 Infectious Diseases, Clinical Science, Anti-Retroviral Agents / adverse effects, HIV Infections / drug therapy, 3. Good health, Stroke, Coronary Disease / epidemiology, Anti-Retroviral Agents, Cardiovascular Diseases, Anti-HIV Agents / adverse effects

Dateibeschreibung: application/pdf; CD4_CD8_Ratio_and_CD8_Cell_Count_and_Their.14.pdf - application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36150371
https://archive-ouverte.unige.ch/unige:173272
https://doi.org/10.1097/qai.0000000000003094
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_F9E3B19F99FD5
https://serval.unil.ch/resource/serval:BIB_F9E3B19F99FD.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_F9E3B19F99FD
https://boris.unibe.ch/173223/
https://www.zora.uzh.ch/id/eprint/225121/
https://doi.org/10.5167/uzh-225121

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials: week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Autoren: Cahn P. Madero J. S. Arribas J. R. et al.

Weitere Verfasser: Cahn P. Madero J. S. Arribas J. R. et al.

Quelle: The Lancet. 393:143-155

Schlagwörter: Male, Lamivudine / therapeutic use, HIV Dolutegravir, Heterocyclic Compounds, 3-Ring / therapeutic use, Tenofovir / therapeutic use, HIV Infections, Viral Load / drug effects, Piperazines, 0302 clinical medicine, Emtricitabine / therapeutic use, Emtricitabine, Tenofovir/adverse effects, Lamivudine/adverse effects, Adult, Anti-HIV Agents, Anti-Retroviral Agents, Double-Blind Method, Drug Therapy, Combination, Female, HIV-1, Heterocyclic Compounds, 3-Ring, Humans, Lamivudine, Middle Aged, RNA, Viral, Tenofovir, Viral Load, Medicine (all), HIV Infections / virology, Heterocyclic Compounds, 3-Ring/adverse effects, 16. Peace & justice, Emtricitabine/adverse effects, Anti-Retroviral Agents / adverse effects, Anti-Retroviral Agents / therapeutic use, HIV-1 / isolation & purification, 3. Good health, [SDV] Life Sciences [q-bio], Anti-HIV Agents / adverse effects, Anti-HIV Agents / therapeutic use, Heterocyclic Compounds, 3-Ring / adverse effects, Tenofovir / adverse effects, Pyridones, HIV Infections/drug therapy, Lamivudine / adverse effects, Anti-Retroviral Agents/adverse effects, 03 medical and health sciences, Emtricitabine / adverse effects, SDG 3 - Good Health and Well-being, Oxazines, HIV-1/isolation & purification, RNA, Viral/blood, Viral Load/drug effects, HIV Infections / drug therapy, Anti-HIV Agents/adverse effects, RNA, Viral / blood

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/30420123
https://air.unimi.it/handle/2434/629086
https://www.sciencedirect.com/science/article/abs/pii/S0140673618324620#!
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)32462-0/fulltext
https://research.monash.edu/en/publications/dolutegravir-plus-lamivudine-versus-dolutegravir-plus-tenofovir-d
https://iris.unimore.it/handle/11380/1221490
https://www.sciencedirect.com/science/article/abs/pii/S0140673618324620
https://biblio.vub.ac.be/vubir/(1ae261bf-adab-4c02-9192-55337e187a2e).html

Predictors of hypertension and changes of blood pressure in HIV-infected patients

Autoren: Thiebaut, R. El-Sadr, W. M. Friis-Moller, N. et al.

Schlagwörter: Adult Aged Aged, 80 and over Anti-Retroviral Agents/adverse effects/therapeutic use Antiretroviral Therapy, Highly Active/adverse effects Blood Pressure/*physiology Cohort Studies Female HIV Infections/*complications/drug therapy/*physiopathology Humans Hypertension/*complications/drug therapy/*physiopathology Longitudinal Studies Male Middle Aged Risk Factors Sex Characteristics Time Factors

Relation: Antiviral Therapy; https://iris.unil.ch/handle/iris/65791; serval:BIB_2390CF9791BC; 000233509500004

Verfügbarkeit: https://iris.unil.ch/handle/iris/65791

No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy.

Autoren: Ortiz, M. Poloni, E.S. Furrer, H. et al.

Weitere Verfasser: Ortiz, M. Poloni, E.S. Furrer, H. et al.

Schlagwörter: Adult, Anti-Retroviral Agents/adverse effects, Case-Control Studies, Cohort Studies, DNA, Mitochondrial/chemistry, Mitochondrial/drug effects, HIV Infections/drug therapy, HIV Infections/genetics, HIV-Associated Lipodystrophy Syndrome/drug therapy, HIV-Associated Lipodystrophy Syndrome/genetics, Haplotypes, Humans, Male, Middle Aged, Sequence Analysis, Switzerland, Thymidine/adverse effects, Thymidine/analogs & derivatives

Dateibeschreibung: application/pdf

Relation: The Journal of Infectious Diseases; https://iris.unil.ch/handle/iris/244599; serval:BIB_EDA298B11FA4; 000287028000008

Verfügbarkeit: https://iris.unil.ch/handle/iris/244599
https://doi.org/10.1093/infdis/jiq106

Infection VIH et personnes âgées [HIV infection and the elderly].

Autoren: Major, K. Clerc, O. Rochat, S. et al.

Schlagwörter: Aged, Anti-Retroviral Agents/administration & dosage, Anti-Retroviral Agents/adverse effects, Cognition Disorders/etiology, Comorbidity, Delayed Diagnosis, HIV Infections/complications, HIV Infections/diagnosis, Humans

Relation: Revue médicale suisse; https://iris.unil.ch/handle/iris/211472; serval:BIB_C9C9649B103F

Verfügbarkeit: https://iris.unil.ch/handle/iris/211472

Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0.

Autoren: Ryom, L. Boesecke, C. Bracchi, M. et al.

Weitere Verfasser: Ryom, L. Boesecke, C. Bracchi, M. et al.

Schlagwörter: AIDS-Related Opportunistic Infections/drug therapy, Adult, Anti-Retroviral Agents/adverse effects, Anti-Retroviral Agents/therapeutic use, Antiretroviral Therapy, Highly Active/adverse effects, Highly Active/methods, Coinfection/drug therapy, Drug Interactions, Europe, Female, HIV Infections/drug therapy, Humans, Male, Practice Guidelines as Topic, Pregnancy, Pregnancy Complications, Infectious/drug therapy, Societies, Scientific, ART, European AIDS Clinical Society guidelines, HBV, HCV, HIV, antiretroviral treatment, coinfections, comorbidities, opportunistic diseases

Dateibeschreibung: application/pdf

Relation: HIV Medicine; https://iris.unil.ch/handle/iris/207273; serval:BIB_81AA6FF34456; 000430107500003

Verfügbarkeit: https://iris.unil.ch/handle/iris/207273
https://doi.org/10.1111/hiv.12600

Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy.

Autoren: Young, J. Glass, T.R. Bernasconi, E. et al.

Weitere Verfasser: Young, J. Glass, T.R. Bernasconi, E. et al.

Schlagwörter: Adult, Anti-HIV Agents/adverse effects, Anti-Retroviral Agents/adverse effects, Antiretroviral Therapy, Highly Active/adverse effects, Female, HIV Infections/complications, HIV Infections/drug therapy, HIV Protease Inhibitors/adverse effects, Humans, Male, Metabolic Syndrome X/chemically induced, Models, Statistical, Oligopeptides/adverse effects, Prospective Studies, Pyridines/adverse effects, Reverse Transcriptase Inhibitors/adverse effects, Risk Factors, Stavudine/adverse effects, Switzerland

Relation: Journal of Clinical Epidemiology; https://iris.unil.ch/handle/iris/180918; serval:BIB_DADAFC5F4F9A; 000266291600013

Verfügbarkeit: https://iris.unil.ch/handle/iris/180918
https://doi.org/10.1016/j.jclinepi.2008.07.015

Peripheral oedema and high arterial blood flow as a complication of antiretroviral therapy.

Autoren: Guyot, S. Hayoz, D. Telenti, A. et al.

Schlagwörter: Adult, Anti-HIV Agents/adverse effects, Anti-Retroviral Agents/adverse effects, Blood Flow Velocity/drug effects, Edema/chemically induced, Female, Femoral Artery/physiology, HIV Infections/drug therapy, Humans, Leg/blood supply, Middle Aged, Skin/blood supply, Stavudine/adverse effects

Relation: AIDS; https://iris.unil.ch/handle/iris/246510; serval:BIB_F7DCFAF6D84C; 000188968100039

Verfügbarkeit: https://iris.unil.ch/handle/iris/246510
https://doi.org/10.1097/00002030-200401230-00039

The renal-bone axis in older people living with HIV on stable antiretroviral therapy: A sub-analysis of the GS-US-104-0423 study

Autoren: Alvarez, Elena Campbell, Lucy Tinago, Willard et al.

Weitere Verfasser: Alvarez, Elena Campbell, Lucy Tinago, Willard et al.

Quelle: Antiviral Therapy. 27

Schlagwörter: Adult, Male, 0301 basic medicine, bone turnover, Anti-HIV Agents, antiretroviral therapy, Anti-Retroviral Agents/adverse effects, HIV Infections/complications, HIV Infections, Kidney, Sciences de la santé humaine, Immunologie & maladie infectieuse, 03 medical and health sciences, Bone Density, renal tubule dysfunction, Humans, Pharmacology (medical), Immunology & infectious disease, Tenofovir/adverse effects, Human health sciences, Tenofovir, Aged, Pharmacology, 0303 health sciences, HIV, Middle Aged, 3. Good health, Infectious Diseases, Cross-Sectional Studies, Anti-Retroviral Agents, Anti-HIV Agents/adverse effects, Female, bone mineral density, Biomarkers

Dateibeschreibung: application/pdf; text/xml

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36000318
https://hdl.handle.net/2268/306248
https://doi.org/10.1177/13596535221094898
https://www.repository.cam.ac.uk/handle/1810/340445
https://doi.org/10.17863/cam.87884
https://doi.org/10.1177/13596535221094898

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection

Autoren: Lundgren, JD Babiker, AG Gordin, F et al.

Quelle: Lundgren, J D, Babiker, A G, Gordin, F, Emery, S, Grund, B, Sharma, S, Avihingsanon, A, Cooper, D A, Fätkenheuer, G, Llibre, J M, Molina, J-M, Munderi, P, Schechter, M, Wood, R, Klingman, K L, Collins, S, Lane, H C, Phillips, A N, Neaton, J D, INSIGHT START Study Group & Pedersen, C 2015, ' Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection ', The New England Journal of Medicine, vol. 373, no. 9, pp. 795-807 . https://doi.org/10.1056/NEJMoa1506816

Schlagwörter: Male, 3207 Medical Microbiology, 32 Biomedical and Clinical Sciences, Kaplan-Meier Estimate, HIV Seropositivity, Viral load, Viral, 3202 Clinical Sciences, anzsrc-for: 3204 Immunology, anzsrc-for: 42 Health sciences, Anti-retroviral agents - adverse effects, 3 Good Health and Well Being, Viral Load, Anti-retroviral agents - administration & dosage, 3. Good health, 3204 Immunology, Infectious Diseases, 2700 Medicine, Anti-Retroviral Agents, 6.1 Pharmaceuticals, HIV - isolation & purification, Medicine, HIV/AIDS, RNA, Viral, anzsrc-for: 3202 Clinical Sciences, Female, Patient Safety, Infection, Adult, Kaplan-Meier estimate, HIV seropositivity - drug therapy, Clinical Trials and Supportive Activities, HIV seropositivity - immunology, Follow-up studies, General & Internal, Time-to-Treatment, anzsrc-for: 32 Biomedical and Clinical Sciences, HIV - genetics, Clinical Research, General & Internal Medicine, Humans, INSIGHT START Study Group, anzsrc-for: 3207 Medical Microbiology, Time-to-treatment, viral - analysis, CD4 lymphocyte count, HIV, Asymptomatic diseases, CD4 Lymphocyte Count, anzsrc-for: 11 Medical and Health Sciences, Asymptomatic Diseases, Sexually Transmitted Infections, RNA, Follow-Up Studies

Zugangs-URL: https://espace.library.uq.edu.au/view/UQ:512043/UQ512043_OA.pdf
https://pubmed.ncbi.nlm.nih.gov/26192873
https://espace.library.uq.edu.au/view/UQ:512043
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569751
https://www.nejm.org/doi/pdf/10.1056/NEJMoa1506816
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569751
https://minnesota-staging.pure.elsevier.com/en/publications/initiation-of-antiretroviral-therapy-in-early-asymptomatic-hiv-in
http://cfar.ucsd.edu/meetings/retrovirus-seminar-series/previous-journal-club-presentations/2015/insight-start-study-group
https://portal.findresearcher.sdu.dk/da/publications/4d7c39b3-33dc-40e1-864d-a454a9ae976f
https://portal.findresearcher.sdu.dk/da/publications/4d7c39b3-33dc-40e1-864d-a454a9ae976f
https://doi.org/10.1056/NEJMoa1506816

Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa

Autoren: Ciaffi, Laura Koulla-Shiro, Sinata Sawadogo, Adrien et al.

Weitere Verfasser: Ciaffi, Laura Koulla-Shiro, Sinata Sawadogo, Adrien et al.

Quelle: AIDS

Schlagwörter: Adult, Male, [SDV.IMM] Life Sciences [q-bio]/Immunology, Drug-Related Side Effects and Adverse Reactions, HIV Infections, Antiretroviral Therapy, Highly Active / methods, Plasma, 03 medical and health sciences, 0302 clinical medicine, Antiretroviral Therapy, Highly Active, Plasma / virology, Antiretroviral Therapy, Highly Active / adverse effects, Humans, Drug-Related Side Effects and Adverse Reactions / epidemiology, Cities, second-line antiretroviral therapy, Second-line antiretroviral therapy, [SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology, HIV, Clinical Science, Middle Aged, Viral Load, randomized clinical trial, Anti-Retroviral Agents / adverse effects, Anti-Retroviral Agents / therapeutic use, HIV Infections / drug therapy, HIV-1 / isolation & purification, 3. Good health, Treatment Outcome, Anti-Retroviral Agents, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Africa, HIV-1, Female, Randomized clinical trial

Dateibeschreibung: application/pdf

Zugangs-URL: https://europepmc.org/articles/pmc4502989?pdf=render
https://pubmed.ncbi.nlm.nih.gov/26244387
https://journals.lww.com/00002030-201507310-00007
https://hal.umontpellier.fr/hal-01959875
https://www.documentation.ird.fr/hor/fdi:010065440
https://pubmed.ncbi.nlm.nih.gov/26244387/
http://journals.lww.com/00002030-201507310-00007
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502989/
http://www.documentation.ird.fr/hor/fdi:010065440

One steroid injection in combination with HIV-medication resulted in a total adrenal insufficiency / Steroid­injektion i kombination med hivläkemedel gav total binjure­barkssvikt

Autoren: Rössner, Sophia Höybye, Charlotte

Quelle: Läkartidningen. 115(15):666

Low plasma levels of the soluble receptor for advanced glycation end products in HIV-infected patients with subclinical carotid atherosclerosis receiving combined antiretroviral therapy

Autoren: Ji Hyeon Baek Su Jin Jeong Young Goo Song et al.

Weitere Verfasser: Ji Hyeon Baek Su Jin Jeong Young Goo Song et al.

Quelle: Atherosclerosis. 219:778-783

Schlagwörter: Adult, Carotid Artery Diseases, Male, Time Factors, Anti-Retroviral Agents/adverse effects, Receptor for Advanced Glycation End Products, Carotid Artery Diseases/etiology, Down-Regulation, HIV Infections, HIV Infections/drug therapy, Risk Assessment, 03 medical and health sciences, 0302 clinical medicine, Drug Therapy, Carotid Artery Diseases/blood, Risk Factors, Soluble receptor for advanced glycation end products, Receptors, Republic of Korea, Humans, Prospective Studies, Receptors, Immunologic, Carotid Arteries/diagnostic imaging, Carotid Artery Diseases/diagnostic imaging, Combined antiretroviral therapy, Tunica Media/diagnostic imaging, Ultrasonography, Analysis of Variance, Chi-Square Distribution, HIV Infections/blood, Middle Aged, Atherosclerosis, HIV infection, Immunologic/blood, 3. Good health, Tunica Intima/diagnostic imaging, Carotid Arteries, Cross-Sectional Studies, Anti-Retroviral Agents, Combination, Asymptomatic Diseases, Linear Models, Drug Therapy, Combination, Carotid artery intima–media thickness, Biomarkers/blood, Biomarkers

Dateibeschreibung: 778~783

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/21872861
https://pubmed.ncbi.nlm.nih.gov/21872861/
https://jglobal.jst.go.jp/en/detail?JGLOBAL_ID=201202242415056614
https://www.ncbi.nlm.nih.gov/pubmed/21872861
https://europepmc.org/article/MED/21872861
https://yonsei.pure.elsevier.com/en/publications/low-plasma-levels-of-the-soluble-receptor-for-advanced-glycation-
https://ir.ymlib.yonsei.ac.kr/handle/22282913/94696

No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial*

Autoren: Mark Bloch Bernard Hirschel Robert Finlayson et al.

Quelle: HIV Medicine, Vol. 11, No 8 (2010) pp. 493-501

Schlagwörter: Adult, Male, Reverse Transcriptase Inhibitors/adverse effects, Ritonavir/therapeutic use, Anti-Retroviral Agents/adverse effects/*therapeutic use, Adiposity/drug effects, HIV Infections, Pyrimidinones, Pyrimidinones/therapeutic use, Lopinavir, Pravastatin/pharmacokinetics/pharmacology/*therapeutic use, 03 medical and health sciences, Absorptiometry, Photon, 0302 clinical medicine, Humans, Uridine, Adiposity, Pravastatin, ddc:616, Ritonavir, Anticholesteremic Agents, HIV-Associated Lipodystrophy Syndrome, Uridine/pharmacokinetics/pharmacology/*therapeutic use, Extremities, Middle Aged, HIV-Associated Lipodystrophy Syndrome/chemically induced/*drug therapy, Dideoxynucleosides, 3. Good health, Anti-Retroviral Agents, Dideoxynucleosides/adverse effects, Reverse Transcriptase Inhibitors, Drug Therapy, Combination, HIV Infections/complications/drug therapy, Anticholesteremic Agents/pharmacokinetics/pharmacology/*therapeutic use

Dateibeschreibung: application/pdf

Zugangs-URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1468-1293.2009.00817.x
https://pubmed.ncbi.nlm.nih.gov/20236365
https://onlinelibrary.wiley.com/doi/full/10.1111/j.1468-1293.2009.00817.x
https://core.ac.uk/display/60829548
https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1468-1293.2009.00817.x
https://archive-ouverte.unige.ch/unige:20818
https://www.cabdirect.org/cabdirect/abstract/20103257539
https://archive-ouverte.unige.ch/unige:20818
https://archive-ouverte.unige.ch/unige:20818
https://doi.org/10.1111/j.1468-1293.2009.00817.x

Incidence and Risk Factors for Chronic Elevation of Alanine Aminotransferase Levels in HIV‐Infected Persons without Hepatitis B or C Virus Co‐Infection

Autoren: Kovari, Helen Ledergerber, Bruno Battegay, Manuel et al.

Weitere Verfasser: Kovari, Helen Ledergerber, Bruno Battegay, Manuel et al.

Quelle: Clinical Infectious Diseases, Vol. 50, No 4 (2010) pp. 502-511
Kovari, Helen; Ledergerber, Bruno; Battegay, Manuel; Rauch, Andri; Hirschel, Bernard; Foguena, Alain Kenfak; Vernazza, Pietro; Bernasconi, Enos; Mueller, Nicolas J; Weber, Rainer (2010). Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection. Clinical infectious diseases, 50(4), pp. 502-11. Cary, N.C.: The University of Chicago Press 10.1086/649922 <http://dx.doi.org/10.1086/649922>

Schlagwörter: Adult, Male, Alcohol Drinking, 610 Medicine & health, HIV Infections, Sensitivity and Specificity, 2726 Microbiology (medical), 10234 Clinic for Infectious Diseases, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Humans, Longitudinal Studies, Poisson Distribution, Prospective Studies, Hepatitis B/enzymology/virology, ddc:616, Liver/enzymology, Alanine Transaminase, 2725 Infectious Diseases, Alcohol Drinking/metabolism, HIV Infections/drug therapy/ enzymology/virology, Middle Aged, Viral Load, Anti-Retroviral Agents/adverse effects/therapeutic use, Hepatitis B, 16. Peace & justice, Hepatitis C, 3. Good health, Anti-Retroviral Agents, Liver, Multivariate Analysis, Female, Alanine Transaminase/blood/ metabolism, Hepatitis C/enzymology/virology

Dateibeschreibung: application/pdf; Chronic_Elevations_of_Alanine_Aminotransferase_2010.pdf - application/pdf; Chronic_Elevations_of_Alanine_Aminotransferase_2.pdf - application/pdf

Zugangs-URL: https://academic.oup.com/cid/article-pdf/50/4/502/1006607/50-4-502.pdf
https://pubmed.ncbi.nlm.nih.gov/20085465
https://academic.oup.com/cid/article/50/4/502/351688
https://archive-ouverte.unige.ch/unige:7391
https://core.ac.uk/display/18165813
https://www.ncbi.nlm.nih.gov/pubmed/20085465
https://www.mendeley.com/catalogue/afc5a2ca-c78b-32bc-8a93-3c90ec58d37d/
https://www.infekt.ch/content/uploads/2013/11/Kovari_2010_Incidence_and_Risk.pdf
https://archive-ouverte.unige.ch/unige:7391
https://archive-ouverte.unige.ch/unige:7391
https://doi.org/10.1086/649922
https://boris.unibe.ch/2728/
http://doc.rero.ch/record/294484/files/50-4-502.pdf
https://www.zora.uzh.ch/id/eprint/38369/
https://doi.org/10.5167/uzh-38369

Antiretroviral therapy for pregnant women living with HIV or hepatitis B: a systematic review and meta-analysis

Autoren: Siemieniuk, Reed A Foroutan, Farid Mirza, Reza et al.

Quelle: ISSN: 2044-6055 ; BMJ Open, vol. 7, no. 9 (2017) e019022.

Schlagwörter: info:eu-repo/classification/ddc/618, Adult, Anti-Retroviral Agents/adverse effects/therapeutic use, Drug Combinations, Emtricitabine/adverse effects/therapeutic use, Female, HIV Infections/complications/drug therapy, Hepatitis B/complications/drug therapy, Humans, Infant, Infectious Disease Transmission, Vertical, Lamivudine/adverse effects/therapeutic use, Lopinavir/adverse effects/therapeutic use, Pregnancy, Pregnancy Complications, Infectious/drug therapy, Pregnancy Outcome, Ritonavir/adverse effects/therapeutic use, Tenofovir/adverse effects/therapeutic use, Young Adult, Zidovudine/adverse effects/therapeutic use

Relation: info:eu-repo/semantics/altIdentifier/pmid/28893758; unige:108128

Verfügbarkeit: https://archive-ouverte.unige.ch/unige:108128

Maraviroc for Previously Treated Patients with R5 HIV-1 Infection

Autoren: Gulick, Roy M Lalezari, Jacob Goodrich, James et al.

Weitere Verfasser: Gulick, Roy M Lalezari, Jacob Goodrich, James et al.

Quelle: New England Journal of Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)

Schlagwörter: Adult, Male, Triazoles/adverse effects/therapeutic use, HIV Infections, Sciences de la santé humaine, Immunologie & maladie infectieuse, Maraviroc, 03 medical and health sciences, Receptors, CCR5/antagonists & inhibitors, 0302 clinical medicine, Double-Blind Method, Cyclohexanes, HIV Fusion Inhibitors, Drug Resistance, Viral, Humans, Immunology & infectious disease, RNA, Viral/blood, Treatment Failure, Human health sciences, HIV Infections/drug therapy/virology, Aged, Sciences bio-médicales et agricoles, Viral Load, Middle Aged, Triazoles, Anti-Retroviral Agents/adverse effects/therapeutic use, HIV-1/chemistry/genetics, CD4 Lymphocyte Count, 3. Good health, Anti-Retroviral Agents, HIV Fusion Inhibitors/adverse effects/therapeutic use, CCR5 Receptor Antagonists, HIV-1, RNA, Viral, Drug Therapy, Combination, Female, Cyclohexanes/adverse effects/therapeutic use

Dateibeschreibung: No full-text files

Zugangs-URL: https://europepmc.org/articles/pmc3078519?pdf=render
https://pubmed.ncbi.nlm.nih.gov/18832244
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=8664
https://www.ncbi.nlm.nih.gov/sites/ppmc/articles/PMC3078519/
https://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/84270/Details
http://swepub.kb.se/bib/swepub:oai:prod.swepub.kib.ki.se:117620559
https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2Ff103cdfe-e483-499a-a911-8218cc98b2ea
https://orbi.uliege.be/handle/2268/16313
http://sro.sussex.ac.uk/id/eprint/45664/

Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection

Autoren: Fätkenheuer, Gerd Nelson, Mark Lazzarin, Adriano et al.

Weitere Verfasser: Fätkenheuer, Gerd Nelson, Mark Lazzarin, Adriano et al.

Quelle: New England Journal of Medicine, Vol. 359, No 14 (2008) pp. 1442-1455

Schlagwörter: Male, 0301 basic medicine, HIV Infections, Enfuvirtide, Immunologie & maladie infectieuse, HIV Envelope Protein gp41/therapeutic use, 0302 clinical medicine, Transaminases/blood, HIV Fusion Inhibitors, Odds Ratio, Ethnicity, Immunology & infectious disease, Human health sciences, ddc:616, HIV Infections/drug therapy/immunology/virology, Receptors, CCR5/antagonists & inhibitors/genetics, Middle Aged, Viral Load, Hepatitis B, Hepatitis C, HIV-1/chemistry/genetics, HIV Envelope Protein gp41, 3. Good health, Treatment Outcome, Anti-Retroviral Agents, HIV Fusion Inhibitors/adverse effects/therapeutic use, CCR5 Receptor Antagonists, Drug Therapy, Combination, Female, Cyclohexanes/adverse effects/therapeutic use, Adult, Genotype, Triazoles/adverse effects/therapeutic use, Ethnic Groups, Sciences de la santé humaine, 03 medical and health sciences, EMC MM-04-28-04, SDG 3 - Good Health and Well-being, Double-Blind Method, Cyclohexanes, Humans, RNA, Viral/blood, Aged, Hepatitis B/blood/complications, Peptide Fragments/therapeutic use, Anti-Retroviral Agents/adverse effects/therapeutic use, CD4 Lymphocyte Count, HIV-1, Hepatitis C/blood/complications

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/18832245
https://pure.eur.nl/en/publications/02d81c5a-0d7c-4757-80b6-550ce7f47f74
https://archive-ouverte.unige.ch/unige:2103
https://orbi.uliege.be/handle/2268/16294
https://www.ncbi.nlm.nih.gov/pubmed/18832245
https://moh-it.pure.elsevier.com/en/publications/subgroup-analyses-of-maraviroc-in-previously-treated-r5-hiv-1-inf
https://europepmc.org/abstract/MED/18832245
https://www.nejm.org/doi/abs/10.1056/NEJMoa0803154
https://archive-ouverte.unige.ch/unige:2103
https://archive-ouverte.unige.ch/unige:2103
https://doi.org/10.1056/nejmoa0803154
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000259631700005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=0c7ff228ccbaaa74236f48834a34396a
https://doi.org/10.1056/NEJMoa0803154
https://hdl.handle.net/11573/84304